These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37152024)

  • 1. Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells.
    Gehre S; Meyer F; Sengedorj A; Grottker F; Reichardt CM; Alomo J; Borgmann K; Frey B; Fietkau R; Rückert M; Gaipl US
    Front Oncol; 2023; 13():981239. PubMed ID: 37152024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells.
    Sengedorj A; Hader M; Heger L; Frey B; Dudziak D; Fietkau R; Ott OJ; Scheidegger S; Barba SM; Gaipl US; Rückert M
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells.
    Wimmer S; Deloch L; Hader M; Derer A; Grottker F; Weissmann T; Hecht M; Gostian AO; Fietkau R; Frey B; Gaipl US
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines.
    Schatz J; Ladinig A; Fietkau R; Putz F; Gaipl US; Frey B; Derer A
    Strahlenther Onkol; 2023 Dec; 199(12):1140-1151. PubMed ID: 36480032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells.
    Grottker F; Gehre S; Reichardt CM; Sengedorj A; Jost T; Rieckmann T; Hecht M; Gostian AO; Frey B; Fietkau R; Gaipl US; Rückert M
    Neoplasia; 2023 Nov; 45():100944. PubMed ID: 37857049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed
    Stoll E; Hader M; Rückert M; Weissmann T; Lettmaier S; Putz F; Hecht M; Fietkau R; Rosin A; Frey B; Gaipl US
    Int J Hyperthermia; 2022; 39(1):796-805. PubMed ID: 35676615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation.
    Kötter B; Frey B; Winderl M; Rubner Y; Scheithauer H; Sieber R; Fietkau R; Gaipl US
    Radiat Oncol; 2015 Sep; 10():197. PubMed ID: 26383236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences of the Immune Phenotype of Breast Cancer Cells after Ex Vivo Hyperthermia by Warm-Water or Microwave Radiation in a Closed-Loop System Alone or in Combination with Radiotherapy.
    Hader M; Savcigil DP; Rosin A; Ponfick P; Gekle S; Wadepohl M; Bekeschus S; Fietkau R; Frey B; Schlücker E; Gaipl US
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32349284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1.
    Lin LC; Lee HT; Chien PJ; Huang YH; Chang MY; Lee YC; Chang WW
    Int J Med Sci; 2020; 17(14):2214-2224. PubMed ID: 32922184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models.
    Cheung A; Chenoweth AM; Quist J; Sow HS; Malaktou C; Ferro R; Hoffmann RM; Osborn G; Sachouli E; French E; Marlow R; Lacy KE; Papa S; Grigoriadis A; Karagiannis SN
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer.
    Mekky RY; Ragab MF; Manie T; Attia AA; Youness RA
    Transl Oncol; 2023 May; 31():101653. PubMed ID: 36907052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors.
    Frey B; Rückert M; Weber J; Mayr X; Derer A; Lotter M; Bert C; Rödel F; Fietkau R; Gaipl US
    Front Immunol; 2017; 8():231. PubMed ID: 28337197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Lu L; Dong J; Wang L; Xia Q; Zhang D; Kim H; Yin T; Fan S; Shen Q
    Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC.
    Meidenbauer J; Wachter M; Schulz SR; Mostafa N; Zülch L; Frey B; Fietkau R; Gaipl US; Jost T
    Front Oncol; 2024; 14():1460150. PubMed ID: 39411143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer.
    Li J; Zhang D; Liu Z; Wang Y; Li X; Wang Z; Liang G; Yuan X; Li Y; Komorowski AL; Rozen WM; Orlandi A; Takabe K; Franceschini G; Jerusalem G; Wang X
    Ann Transl Med; 2023 Jan; 11(2):83. PubMed ID: 36819490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression Profiles Induced by High-dose Ionizing Radiation in MDA-MB-231 Triple-negative Breast Cancer Cell Line.
    Bravatà V; Cammarata FP; Minafra L; Musso R; Pucci G; Spada M; Fazio I; Russo G; Forte GI
    Cancer Genomics Proteomics; 2019; 16(4):257-266. PubMed ID: 31243106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and lipidomic characterization of radioresistant MDA-MB-231 human breast cancer cells to investigate potential therapeutic targets.
    Lee H; To NB; Kim M; Nguyen YT; Cho SK; Choi HK
    J Pharm Biomed Anal; 2022 Jan; 208():114449. PubMed ID: 34749107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.
    Pierini S; Mishra A; Perales-Linares R; Uribe-Herranz M; Beghi S; Giglio A; Pustylnikov S; Costabile F; Rafail S; Amici A; Facciponte JG; Koumenis C; Facciabene A
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
    Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.